This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Calculated concentration—Enter both values above.
Optional conversion
Enter a target amount you already have and select the syringe capacity.
Calculated draw—Enter concentration inputs and a target amount.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
Protocol
Phase
Frequency
Amount
Notes
Standard
1–3×/week
0.5–1 mL
IM upper outer glute preferred; SubQ acceptable. 1 mL/week is most common maintenance.
Off
2–4 weeks
–
Reassess at 16–20 weeks. No mandatory off if tolerated.
Cycle & Timing
Ongoing 8–12 week blocks. Reassess at 16–20 weeks.
Timing
3×/week IM, anytime; typically AM.
Population Considerations
Unisex lipolytic / carnitine blend, dose by protocol; no meaningful sex difference. Avoid in pregnancy.
Handling & Stacking
Injection site
IM upper outer glute preferred; SubQ acceptable.
Storage
Solution: refrigerate 36–46°F.
Use within 30 days.
Protect from light.
There's no real community potency figure for LC120; it's a small-molecule cofactor blend, so the practical limit is sterility at ~28–30 days refrigerated and dark, not peptide potency.
Component allergies (B12, riboflavin, lecithin, choline, methionine, lidocaine) Hypothyroid medication, separate by 4 hours Severe hepatic impairment (choline metabolism) Pregnancy and lactation, specific compounding required Bleeding disorders or anticoagulants (relative), bruising risk
Warnings
Compounded products, composition varies; request the pharmacy’s COA B12 (cyanocobalamin) contains cobalt, allergy possible Methionine elevates homocysteine in some individuals L-Carnitine: TMAO conversion concern in CV disease (controversial, baseline lipids) Injection-site reactions common with phosphatidylcholine
Drug interactions
Warfarin: L-carnitine and choline blends can potentiate, monitor INR if combining Levothyroxine: separate by 4 hours, choline/B-vitamins affect absorption Anticoagulants / antiplatelets (DOACs, aspirin, clopidogrel): bruising risk with phosphatidylcholine Insulin / antidiabetics: B-complex may shift glucose, recheck log if dosing changes Methotrexate, trimethoprim, phenytoin: deplete folate / B12; coordinate with prescriber Lidocaine blends (LC526): avoid other caines same session, additive cardiac effects Stimulants / phentermine: additive CV load with high-dose lipotropics, monitor BP/HR
Fishy odor from choline/L-carnitine is normal, not allergic Inject slowly to reduce stinging Don’t use with warfarin without physician guidance (potentiation risk) Request exact ingredient list and concentrations from your compounder
References
peptidedosages · PubMed · thepeptidereport
KEEP EXPLORING
Related Compounds
Explore other research profiles in Blends and Mixed Protocols.
Standard Labs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
